Conference Coverage

An enlightened approach to weight loss using liraglutide


 

AT OBESITY WEEK 2016

This analysis and the clinical trials on which it was based were sponsored by Novo Nordisk, which markets liraglutide under the brand names Saxenda and Voctoza. The presenter reported receiving research grants from and serving as a consultant to Novo Nordisk and other pharmaceutical companies.

Pages

Recommended Reading

Roux-en-Y gastric bypass associated with long-term weight loss
MDedge Family Medicine
Patient-reported outcomes tied to long-term outcomes in bariatric surgery
MDedge Family Medicine
OMA publishes pediatric obesity treatment guide
MDedge Family Medicine
Nonalcoholic fatty liver disease estimated to cost $103 billion annually
MDedge Family Medicine
Many overweight Parkinson’s patients have insulin resistance
MDedge Family Medicine
Is the Rx to blame for the patient’s weight gain?
MDedge Family Medicine
Drug-induced weight gain: Rethinking our choices
MDedge Family Medicine
Obesity risk rises when kids aren’t active 1 hour a day
MDedge Family Medicine
New screen time guidelines address rapid changes in media environment
MDedge Family Medicine
Body-size awareness linked with BMI decrease in obese children, teens
MDedge Family Medicine